Thus, oncocytic differentiation in chromophobe RCC could be interpreted as a remaining feature from an oncocytic tumor which can be transformed into a chromophobe RCC by acquiring p53 mutations [40]. The gene discussed is TP53; the disease is oncocytic neoplasm.